Regorafenib (BAY 73-4506) in Advanced Colorectal Cancer: A Phase I Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2012.153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Regorafenib Okayed for Colorectal Cancer

Cancer Discovery
Oncology
2012English

Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer

Investigational New Drugs
OncologyPharmacology
2015English

Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Phase I Study of Telatinib (BAY 57-9352): Analysis of Safety, Pharmacokinetics, Tumor Efficacy, and Biomarkers in Patients With Colorectal Cancer

Vascular Cell
Computer NetworksDevelopmental NeuroscienceNeurologyCell BiologyCommunications
2011English

Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2019English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Long‐term Survival of an Advanced Colorectal Cancer Patient Treated With Regorafenib: Case Report and Literature Review

Clinical Case Reports
Medicine
2019English

A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy